JSR Corp. (TYO:4185) is working on the Japanese launch of pre-clinical trial services that utilize cancer organoids, which are tumor-derived……
Please subscribe to read the full story.
Author
JSR Corp. (TYO:4185) is working on the Japanese launch of pre-clinical trial services that utilize cancer organoids, which are tumor-derived……
Please subscribe to read the full story.
